Home Cart Sign in  
Chemical Structure| 7554-65-6 Chemical Structure| 7554-65-6

Structure of Fomepizole
CAS No.: 7554-65-6

Chemical Structure| 7554-65-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Fomepizole is a competitive inhibitor of the enzyme alcohol dehydrogenase which plays a key role in the metabolism of ethylene glycol and methanol.

Synonyms: 4-Methylpyrazole; Antizol; Fomepizolum

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations

Bradley B. Garrison ; Joseph E. Duhamel ; Nehemiah Antoine ; Steven J. K. Symes ; Kyle A. Grice ; Colin D. McMillen , et al.

Abstract: 4-(tris(4-methyl-1H-pyrazol-1-yl)methyl)aniline was prepared in a 63% yield utilizing a C–F activation strategy from a mixture of 4-(trifluoromethyl)aniline, 4-methylpyrazole, and KOH in dimethylsulfoxide (DMSO). The identity of the product was confirmed by nuclear magnetic resonance spectroscopy, infrared spectroscopy, mass spectrometry, and single-crystal analysis. An analysis of crystals grown from the layering method (CH2Cl2/acetone/pentane) indicated two distinct polymorphs of the title compound. Moreover, density functional theory calculations utilizing the MN15L density functional and the def2-TZVP basis set indicated that 4-(tris(4-methyl-1H-pyrazol-1-yl)methyl)aniline forms with similar energetics to the previously reported unmethylated analog.

Keywords: tris(pyrazolyl)methane ; ligand ; C–F activation ; crystallography ; polymorphs ; DFT

Purchased from AmBeed: ;

Alternative Products

Product Details of Fomepizole

CAS No. :7554-65-6
Formula : C4H6N2
M.W : 82.10
SMILES Code : C1=N[NH]C=C1C
Synonyms :
4-Methylpyrazole; Antizol; Fomepizolum
MDL No. :MFCD00005245
InChI Key :RIKMMFOAQPJVMX-UHFFFAOYSA-N
Pubchem ID :3406

Safety of Fomepizole

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P261-P280-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • Dehydrogenase

In Vitro:

Cell Line
Concentration Treated Time Description References
Mouse pancreatic acinar cells 100 µM 10 minutes Investigated the effects of ethanol and palmitoleic acid (POA) on intracellular calcium concentration, showing that inhibition of oxidative metabolism by 4-MP (Fomepizole) converted transient calcium signals induced by ethanol/POA to sustained elevations, leading to mitochondrial depolarization and cellular necrosis. These effects were completely blocked by 3-BCP (a CEL inhibitor). PMC4112447
Primary human hepatocytes 10 mM or 20 mM 48 hours Evaluate the protective effects of 4MP and NAC on APAP-induced cell death. 4MP at both concentrations significantly prevented APAP-induced cell death, while NAC was only partially effective at the highest concentration. PMC8448936
J774A.1 cells 2 mM 1 hour To assess the effect of 4MP and JNK inhibitor on endotoxin-induced cell activation, results showed that the combination of 4MP and JNK inhibitor attenuated the release of NOx and IL-6 in an almost additive manner PMC11628662
Primary human kidney cells 2 mM 24 or 48 hours Evaluate the protective effect of 4MP against APAP-induced cell death, results showed that 4MP significantly reduced APAP-induced cell death PMC11097675
Mouse epidermis extracts 1 mM 1 hour To investigate the ability of mouse epidermis extracts to convert retinol to retinoic acid, showing effective oxidation of retinol to retinoic acid in the presence of NAD+. PMC1148017

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
CD1 mice Alcoholic acute pancreatitis model Intraperitoneal injection 10 mg/kg Two injections at 1-hour intervals, observed for 24 hours Evaluated the effects of 4-MP (Fomepizole) on alcoholic acute pancreatitis, showing that 4-MP exacerbated pancreatic damage and inflammation by inhibiting oxidative metabolism and promoting non-oxidative pathways. 3-BCP (a CEL inhibitor) significantly inhibited pancreatic FAEE elevation and ameliorated pancreatic damage and inflammation. PMC4112447
Mice APAP-induced liver injury model Intravenous 15 mg/kg and 10 mg/kg Two doses 12 hours apart Evaluate the protective effect of Fomepizole on APAP-induced liver injury, showing that Fomepizole effectively prevents liver injury by inhibiting Cyp2E1 and JNK activation. PMC8837711
Mice APAP-induced hepatotoxicity model 50 mg/kg Immediately after APAP administration To evaluate the protective effect of fomepizole against APAP hepatotoxicity, results showed that fomepizole significantly reduced plasma ALT elevations and centrilobular necrosis PMC11315809
C57BL/6J mice APAP-induced hepatotoxicity model Intraperitoneal injection Initial dose 184.5 mg/kg, maintenance dose 123 mg/kg Every 12 hours until euthanasia Evaluate the protective effects of 4MP on APAP-induced hepatotoxicity. 4MP significantly attenuated liver injury at 24h and promoted recovery at 48h, which correlated with enhanced mitochondrial biogenesis and hepatocyte proliferation. PMC8448936
C57BL/6J mice Non-obese metabolic dysfunction-associated steatotic liver disease (MASLD) model Intraperitoneal injection 50 mg/kg body weight Once weekly for 8 weeks To assess the effect of 4MP on the development of MASLD, results showed that 4MP treatment significantly attenuated the increase in JNK phosphorylation and pro-inflammatory markers (e.g., IFNγ, IL-6, and 3-nitrotyrosine protein adducts) in liver tissue, but did not affect impairments in glucose tolerance or the increase in portal endotoxin levels PMC11628662
C57BL/6J mice APAP-induced acute kidney injury model Intraperitoneal injection 50 mg/kg Single dose, euthanized at 24 hours Evaluate the protective effect of 4MP against APAP-induced kidney injury, results showed that 4MP significantly reduced APAP-induced kidney injury and ER stress PMC11097675

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02415712 Ethylene Glycol Poisoning, Met... More >>hanol Poisoning Less << COMPLETED 2022-06-30 Takeda Sponsored Site, Osaka, ... More >>Japan|Takeda Sponsored Site, Tokyo, Japan Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

12.18mL

2.44mL

1.22mL

60.90mL

12.18mL

6.09mL

121.80mL

24.36mL

12.18mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories